Caroline Xu

Company: ViGeneron GmbH

Job title: Co-Founder & CEO

Seminars:

Panel Discussion: Advancing Gene Therapy Vectors with More Insightful Investment 3:00 pm

Discussing the importance of investment into the gene therapy vector space to characterize attractive investment prospects Refocusing investment strategies to primarily propel vector therapy innovation Determining how workflows and mindsets from the antibody therapy space may hinder vector therapies from reaching their potential Read more

day: Conference Day Two